Stability-indicating methods for quantitative determination of zidovudine and stavudine in capsules
AUTOR(ES)
Santoro, Maria Inês R. M., Taborianski, Andréia M., Singh, Anil Kumar, Kedor-Hackmann, Erika R. M.
FONTE
Química Nova
DATA DE PUBLICAÇÃO
2006-04
RESUMO
Zidovudine (AZT) and stavudine (D4T) are nucleoside reverse transcriptase inhibitors extensively used in human immunodeficiency virus (HIV) infected patients. In order to evaluate the quality of these drugs, two stability indicating HPLC methods were developed. The validated methods were applied in quantitative determination of AZT, D4T and their induced degradation products in capsule preparations. The stability studies were conducted at controlled temperature and relative humidity conditions based on the International Conference on Harmonization stability studies protocol for Zone IV areas. Easy sample preparation and low-cost make these methods especially useful for quality control and stability studies of AZT and D4T in drug products.
Documentos Relacionados
- Stability-indicating comparative methods using mekc and lc for determination of olmesartan medoxomil
- Stability-indicating liquid chromatographic and UV spectrophotometric methods for the quantification of ciprofibrate in capsules and tablets
- Stability-indicating RP-HPLC method for determination of beclomethasone dipropionate in nanocapsule suspensions
- Stability-indicating RP-HPLC method for simultaneous determination of gatifloxacin and flurbiprofen in binary combination
- Stability-indicating HPLC determination of pramipexole dihydrochloride in bulk drug and pharmaceutical dosage form